Carbohydrate T Cell Epitope Conjugates Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for scaling up the production of MAG-Tn3, a synthetic immunogen, face challenges in controlling the incorporation of Tn residues, leading to impurities and reduced yields due to the incorporation of fully unprotected sugar, making large-scale purification complex.
Innovation Solution
Protecting the hydroxyl groups of the carbohydrate B cell epitope with suitable groups like allyl, p-methoxybenzyl, or acetyl before incorporation into the dendrimeric peptide building block, allowing for better control of the epitope incorporation and improving yields and purity through a protected carbohydrate T cell epitope conjugate intermediate, which is then deprotected to form the final conjugate.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If the carbohydrate Tn3 antigen is incorporated with the fully unprotected sugar, then the final deprotection step is avoided, but the extra-incorporation of Tn residues becomes difficult to control and affects the crude purity and overall yield
Solution Approach 1:
The patent applies preliminary action by protecting the hydroxyl groups of the carbohydrate Tn3 antigen with protecting groups (such as acetyl, benzyl, or p-methoxybenzyl groups) before incorporation into the dendrimeric peptide building block. This preliminary protection step enables precise control of Tn residue incorporation during the coupling reaction, preventing extra-incorporation issues that plague the unprotected sugar approach. The protecting groups are subsequently removed in a controlled deprotection step after successful incorporation, ensuring both manufacturing precision and process efficiency.
2Productivity
If the fully unprotected sugar is used for incorporation, then the deprotection step is eliminated, but the purification of high molecular weight glycopeptide becomes complex
Solution Approach 1:
The patent employs protecting groups as intermediary elements that facilitate the purification process. By incorporating the carbohydrate antigen with protecting groups attached, the molecule acquires distinct chromatographic properties that enable efficient separation from impurities and side products during purification. The protecting groups act as temporary mediators that simplify the purification of high molecular weight glycopeptide conjugates, after which they are removed to yield the final product with high purity.
3Quantity of substance
If scaling up the production of MAG-Tn3 is attempted, then large-scale synthesis is achieved, but the control of Tn residue incorporation deteriorates leading to impurities and reduced yields
Solution Approach 1:
The patent successfully scales up production by maintaining the preliminary protection strategy. The protecting groups on the carbohydrate antigen provide steric and electronic control that prevents extra-incorporation of Tn residues, even in large-scale reactions where concentration effects and mixing variability might otherwise compromise precision. This preliminary action ensures that manufacturing precision is maintained across different production scales, from milligram to gram quantities.
Data Source
AI summary
The present invention relates to a method for preparing carbohydrate T cell epitope conjugates of formula (I): M(T-B)n (I) wherein M, T, B and n ore as defined in claim 1.